164 related articles for article (PubMed ID: 19118376)
41. [Pathogenesis and treatment of follicular lymphoma].
Nishikori M
Nihon Rinsho; 2012 Apr; 70 Suppl 2():477-81. PubMed ID: 23134002
[No Abstract] [Full Text] [Related]
42. Follicular NHL: from antibodies and vaccines to graft-versus-lymphoma effects.
Maloney DG
Hematology Am Soc Hematol Educ Program; 2007; ():226-32. PubMed ID: 18024634
[TBL] [Abstract][Full Text] [Related]
43. Fibrosis in low-grade follicular lymphoma - a link to the TH2 immune reaction.
Lohneis P; Wienert S; Klauschen F; Anagnostopoulos I; Jöhrens K
Leuk Lymphoma; 2017 May; 58(5):1190-1196. PubMed ID: 27736316
[TBL] [Abstract][Full Text] [Related]
44. Composite follicular lymphoma and nodular lymphocyte predominance Hodgkin's disease.
Dargent JL; Lespagnard L; Meiers I; Bradstreet C; Heimann P; De Wolf-Peeters C
Virchows Arch; 2005 Oct; 447(4):778-80. PubMed ID: 15983819
[No Abstract] [Full Text] [Related]
45. Composite lymphoma of the orbit treated with rituximab.
Kang SJ; Schmack I; Wojno TH; Grossniklaus HE
Ophthalmic Plast Reconstr Surg; 2007; 23(2):143-4. PubMed ID: 17413631
[TBL] [Abstract][Full Text] [Related]
46. Histone deacetylase inhibition as a mechanism for the therapeutic effect of statins (3-hydroxy-3-methylglutaryl-coenzyme a reductase inhibitors) in follicular lymphoma.
Barker CA; Yahalom J
J Clin Oncol; 2010 Aug; 28(24):e426; author reply e427-8. PubMed ID: 20566995
[No Abstract] [Full Text] [Related]
47. Identification of MUM1 as a prognostic immunohistochemical marker in follicular lymphoma using computerized image analysis.
Xerri L; Bachy E; Fabiani B; Canioni D; Chassagne-Clément C; Dartigues-Cuilléres P; Charlotte F; Brousse N; Rousselet MC; Foussard C; Brice P; Feugier P; Morschhauser F; Sonet A; Olive D; Salles G;
Hum Pathol; 2014 Oct; 45(10):2085-93. PubMed ID: 25149549
[TBL] [Abstract][Full Text] [Related]
48. Analysis of dendritic cell subpopulations in follicular lymphoma with respect to the tumor immune microenvironment.
Chevalier N; Mueller M; Mougiakakos D; Ihorst G; Marks R; Schmitt-Graeff A; Veelken H
Leuk Lymphoma; 2016 Sep; 57(9):2150-60. PubMed ID: 26757600
[TBL] [Abstract][Full Text] [Related]
49. Intralesional rituximab: a new therapeutic approach for patients with conjunctival lymphomas.
Ferreri AJ; Govi S; Colucci A; Crocchiolo R; Modorati G
Ophthalmology; 2011 Jan; 118(1):24-8. PubMed ID: 20709407
[TBL] [Abstract][Full Text] [Related]
50. Classification updates and clinical investigations in indolent non-Hodgkin lymphoma.
Cheson BD
Clin Adv Hematol Oncol; 2008 Sep; 6(9):4-6. PubMed ID: 18998258
[No Abstract] [Full Text] [Related]
51. Peripheral blood involvement in patients with follicular lymphoma: a rare disease manifestation associated with poor prognosis.
Sarkozy C; Baseggio L; Feugier P; Callet-Bauchu E; Karlin L; Seymour JF; Lebras L; Michallet AS; Offner F; Dumas O; Traverse-Glehen A; Ffrench M; Lopez-Guillermo A; Berger F; Coiffier B; Felman P; Salles G
Br J Haematol; 2014 Mar; 164(5):659-67. PubMed ID: 24274024
[TBL] [Abstract][Full Text] [Related]
52. Pathology, pathogenesis and molecular genetics of follicular NHL.
Leich E; Ott G; Rosenwald A
Best Pract Res Clin Haematol; 2011 Jun; 24(2):95-109. PubMed ID: 21658611
[TBL] [Abstract][Full Text] [Related]
53. Does a diffuse growth pattern predict for survival in patients with low-grade follicular lymphoma?
Bhagavathi S; Gu K; Loberiza FR; Bast M; Vose JM; Weisenburger DD
Leuk Lymphoma; 2009 Jun; 50(6):900-3. PubMed ID: 19504394
[TBL] [Abstract][Full Text] [Related]
54. Follicular lymphoma of the salivary gland: a clinicopathological and molecular study of six cases.
Kojima M; Nakamura S; Ichimura K; Shimizu K; Itoh H; Masawa N
Int J Surg Pathol; 2001 Oct; 9(4):287-93. PubMed ID: 12574844
[TBL] [Abstract][Full Text] [Related]
55. Signal transducers and activators of transcription 5a-dependent cross-talk between follicular lymphoma cells and tumor microenvironment characterizes a group of patients with improved outcome after R-CHOP.
Taskinen M; Valo E; Karjalainen-Lindsberg ML; Hautaniemi S; Meri S; Leppä S
Clin Cancer Res; 2010 May; 16(9):2615-23. PubMed ID: 20388848
[TBL] [Abstract][Full Text] [Related]
56. Rituximab maintenance in follicular lymphoma.
Barr PM
Clin Adv Hematol Oncol; 2015 Mar; 13(3):158-61. PubMed ID: 26352422
[No Abstract] [Full Text] [Related]
57. Prognostic significance of p53 and matrix metalloproteinase-9 expression in follicular lymphoma.
Pennanen H; Kuittinen O; Soini Y; Turpeenniemi-Hujanen T
Eur J Haematol; 2008 Oct; 81(4):289-97. PubMed ID: 18616513
[TBL] [Abstract][Full Text] [Related]
58. An imaging-based rapid evaluation method for complement-dependent cytotoxicity discriminated clinical response to rituximab-containing chemotherapy.
Mishima Y; Sugimura N; Matsumoto-Mishima Y; Terui Y; Takeuchi K; Asai S; Ennishi D; Asai H; Yokoyama M; Kojima K; Hatake K
Clin Cancer Res; 2009 May; 15(10):3624-32. PubMed ID: 19417028
[TBL] [Abstract][Full Text] [Related]
59. Prognostic Impact of Natural Killer Cell Count in Follicular Lymphoma and Diffuse Large B-cell Lymphoma Patients Treated with Immunochemotherapy.
Klanova M; Oestergaard MZ; Trněný M; Hiddemann W; Marcus R; Sehn LH; Vitolo U; Bazeos A; Goede V; Zeuner H; Knapp A; Sahin D; Spielewoy N; Bolen CR; Cardona A; Klein C; Venstrom JM; Nielsen T; Fingerle-Rowson G
Clin Cancer Res; 2019 Aug; 25(15):4634-4643. PubMed ID: 31053601
[TBL] [Abstract][Full Text] [Related]
60. Transformation of follicular lymphoma - Why does it happen and can it be prevented?
Link BK
Best Pract Res Clin Haematol; 2018 Mar; 31(1):49-56. PubMed ID: 29452666
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
